Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing.
Dou Y, Darvas M, Sharma K, Mathieu J, Morton J, Tan H, Soto-Palma C, Angelini LA, McGowan SJ, Niedernhofer LJ, Suh Y, Robbins PD, Barzilai N, Ladiges WC.
Dou Y, et al.
Trends Biomed Res. 2020 Dec;3(1):121. doi: 10.15761/jtbr.1000121. Epub 2020 Oct 8.
Trends Biomed Res. 2020.
PMID: 37113577
Free PMC article.